Plus LibraryBy pinki@katapult.biz / February 13, 2025 Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title of Presentation Type of Media — Video Document Audio Event 2024 Event — 2024 California Cancer Consortium Conference (CCC) 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS 2024 MaTOS Lungs 2025 PRIMO Clear Displaying 1,551 - 1,575 of 2,875 « 1 … 61 62 63 64 65 … 115 » EGFR Common and Uncommon Mutations & What Is Next For This Patient Population Edgardo S. Santos, MD, FACP View PDF EGFR & ALK: Where are We Now Edgardo S. Santos, MD, FACP View PDF New Landscape of Mutant EGFR & ALK Lung Cancer Patients Edgardo S. Santos, MD, FACP View PDF RET, MET, & NTRK in Non-Small Cell Lung Cancer Edgardo S. Santos, MD, FACP View PDF RET, MET, and BRAF Mutant Lung Cancer Tumors Edgardo S. Santos, MD, FACP View PDF Other Driver Mutations: ROS-1, RET, HER-2, MET & Exon 20 Insertions Edgardo S. Santos, MD, FACP View PDF Targeted Therapy in Non-Squamous NSCLC: Where Are We and What Is Coming Up? Edgardo S. Santos, MD, FACP View PDF EGFR/ALK and ROS-1 Lung Cancer Management Edgardo S. Santos, MD, FACP View PDF Lung Targeted Therapies IN NSCLC: EGFR, ALK, and ROS1 Edgardo S. Santos, MD, FACP View PDF Advances in Targeted Therapy in Lung Cancer Edgardo S. Santos, MD, FACP View PDF Lung Targeted Therapies IN NSCLC: EGFR, ALK, and ROS1 Edgardo S. Santos, MD, FACP View Video Advances in Targeted Therapy in Lung Cancer Edgardo S. Santos, MD, FACP View Video Dealing with EGFRex19del & L858R, ALK, and KRASg12c Genetic Aberrations Edgardo S. Santos, MD, FACP View PDF Dealing with EGFRex19del & L858R, ALK, and KRASg12c Genetic Aberrations Edgardo S. Santos, MD, FACP View Video EGFR PKI Resistance and K-RAS Mutations Edgardo S. Santos, MD, FACP View PDF Targeted Therapy in Lung Cancer Edgardo S. Santos, MD, FACP View PDF Targeted Therapy in Lung Cancer Edgardo S. Santos, MD, FACP View Video Advances in Targeted Therapy in Lung Cancer Edgardo S. Santos, MD, FACP View PDF Advances in Targeted Therapy in Lung Cancer Edgardo S. Santos, MD, FACP View Video EGFR PKI Resistance and K-RAS Mutations Edgardo S. Santos, MD, FACP View Video Metastatic Targeted Therapy Updates Edgardo S. Santos, MD, FACP View PDF New Developments in EGFR and K-RAS Therapies in NSCLC Edgardo S. Santos, MD, FACP View PDF Front Line Targeted Therapy in NSCLC: Tyrosine Kinase Inhibitors Edgardo S. Santos, MD, FACP View PDF New Developments in EGFR and K-RAS Therapies in NSCLC Edgardo S. Santos, MD, FACP View Video Front Line Targeted Therapy in NSCLC: Tyrosine Kinase Inhibitors Edgardo S. Santos, MD, FACP View Video
